ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

-

SETB. 2011; 45(1): 1-7


Comparison of residual curarization after extubation with clinical observation using either rocuronium or atracurium

Ayşe Hancı, G. Ulufer Sivrikaya, Birsen Ekşioğlu, Leyla T. Kılınç, Melahat K. Erol.



Abstract
Download PDF Post

Objective: In our study we aimed to compare the residual curarization after extubation with clinical observation using either rocuronium or atracurium which were antagonized with neostigmine.

Methods: Sixty patients in ASA I-II physical status undergoing abdominal hysterectomy operation were randomly assigned to two groups as: planned to apply rocuronium 0.6 mg.kg-1 to extubate with clinical observation (Group R); atracurium 0.5 mg.kg-1 to extubate with clinical observation (Group A). At the end of the operation all patients were antagonized with neostigmine. TOF values at extubation and at 1., 3., 5., 10. minutes after extubation, operation and anaesthesia times, total fentanyl, neuromuscular blocker agent and neostigmine doses were recorded.

Results: Demographic characteristics of the patients, duration of operation and anaesthesia, total fentanyl, neuromuscular blocker, neostigmine doses were similar in four groups. TOF ratio was

Key words: Neuromuscular block, monitoring, residual curarization, rocuronium, atracurium





Bibliomed Article Statistics

17
23
22
16
19
38
20
27
30
30
25
16
R
E
A
D
S

22

16

8

11

9

31

19

8

21

8

12

7
D
O
W
N
L
O
A
D
S
080910111201020304050607
20242025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.